MedPath

A RANDOMISED STUDY TO COMPARE THE REDUCED INTENSIVE REGIMEN CONTAINING ALEMTUZUMAB VERSUS ATG IN ALLOGENIC TRAPIANTS FROM MUD

Conditions
CONDITIONING WITH REDUCED INTENSIVE REGIMEN IN ALLOGENI TRANSPLANT FROM MUD
Registration Number
EUCTR2005-000805-68-IT
Lead Sponsor
AZIENDA OSPEDALIERA OSPEDALI RIUNITI DI BERGAMO A.O. DI RILIEVO NAZIONALE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: ;Secondary Objective: ;Primary end point(s):
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath